Treatment Perspectives in Multiple Myeloma

Eric, a patient with multiple myeloma, and Sally, his wife and care partner, share their

Eric, a patient with multiple myeloma, and Sally, his wife and care partner, share their journey with chimeric antigen receptor T-cell (CAR T) therapy, from infusion to post-treatment recovery. They discuss how they navigated the monitoring and treatment of adverse effects. Furthermore, Sally highlights the importance of clear communication with the healthcare team during the recovery process.

Eric, his wife and care partner Sally, and Eric’s oncologist, Omar Castaneda Puglianini, MD, discuss Eric’s multiple myeloma diagnosis and treatment journey. Upon his first relapse, he decided that CAR T therapy was right for him, as he wanted to maintain his active lifestyle. Eric and Sally also describe the support they’ve received from their healthcare team throughout the course of treatment. Additionally, Dr. Castaneda Puglianini clears up some misconceptions about CAR T therapy, such as concerns related to patient eligibility and post-treatment recovery.

Tony and his best friend, Michael, discuss Tony’s journey with CAR-T therapy and the network of care partners who provided support during his journey. Michael and Tony share wisdom on identifying care partners within your support network, as well as helpful financial resources for CAR-T recipients and their care partners to aid them in their journey.

Hear Tony’s experience recovering after CAR-T therapy for multiple myeloma and learn about financial and travel resources that may support treatment.

Tony, who was diagnosed with multiple myeloma in 2013, and his oncologist, Dr. Peter Voorhees, discuss Tony’s story. Tony shares navigating his diagnosis and Dr. Voorhees emphasizes the importance of early detection. Later, the two discuss Tony’s discovery and exploration of CAR-T therapy as a possible treatment for his disease.